(Q82029827)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808988%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808988%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

main subject

AIDS dementia complex

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808988%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Paola Cinque

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808988%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Magnus Gisslen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808988%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Lars Hagberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808988%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Richard W Price

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808988%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808988%20AND%20SRC:MED&resulttype=core&format=json

Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn

14 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808988%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808988%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

261-300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808988%20AND%20SRC:MED&resulttype=core&format=json

Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection

14 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Effects of antiretroviral treatment on blood-brain barrier integrity and intrathecal immunoglobulin production in neuroasymptomatic HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Rate and severity of HIV-associated dementia (HAD): correlations with Gp41 and iNOS

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid lymphocytes from HIV-infected patients synthesize HIV-specific antibody in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Increased cerebrospinal fluid protein tau concentration in neuro-AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Increased cerebrospinal fluid ganglioside GD3 concentrations as a marker of microglial activation in HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Higher HIV-1 RNA cutoff level required in cerebrospinal fluid than in blood to predict positive HIV-1 isolation

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Increasing intrathecal lymphocytosis and immunoglobulin G production in neurologically asymptomatic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

CSF markers for Alzheimer's disease: Total tau, phospho-tau and Aβ42

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid abnormalities in patients without AIDS who are seropositive for the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Chemokines in pathology and medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Characterization of chemokines and their receptors in the central nervous system: physiopathological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Viral genome characterisation by the heteroduplex mobility and heteroduplex tracking assays

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

The microglial cell. A historical review

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

14-3-3 proteins in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid proteomics and human immunodeficiency virus dementia: preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Long-term virological effect of highly active antiretroviral therapy on cerebrospinal fluid and relationship with genotypic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid protein biomarkers for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Nitric oxide synthesis enhances human immunodeficiency virus replication in primary human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Primary sensory neurons migrate in response to the chemokine RANTES

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Influence of neurologic manifestations of primary human immunodeficiency virus infection on disease progression. SEROCO Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Brain-derived HIV-1 tat sequences from AIDS patients with dementia show increased molecular heterogeneity.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid HIV-1 p24 antigen and culture: sensitivity and specificity for AIDS-dementia complex

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

CSF amyloid beta42 and tau levels correlate with AIDS dementia complex

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Effect of GP120 on glutathione peroxidase activity in cortical cultures and the interaction with steroid hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Presence of mutation conferring resistance to lamivudine in plasma and cerebrospinal fluid of HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Longitudinal Analysis ofnef/Long Terminal Repeat–Deleted HIV‐1 in Blood and Cerebrospinal Fluid of a Long‐Term Survivor Who Developed HIV‐Associated Dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Intrathecal synthesis of interleukin-2 and soluble IL-2 receptor in asymptomatic HIV-1 seropositive individuals. Correlation with local production of specific IgM and IgG antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

High cerebrospinal fluid and serum levels of tumor necrosis factor-alpha in asymptomatic HIV-1 seropositive individuals. Correlation with interleukin-2 and soluble IL-2 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Diagnosis of central nervous system complications in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Assessing chemokine co-receptor usage in HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Proteome studies of CSF in AD patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

HIV antibody profiles in serum and CSF of patients with neurological disease can serve as predictors of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

HIV type 1 V3 sequences and the development of dementia during AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Astrocytes express functional chemokine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid tau protein is not elevated in HIV-associated neurologic disease in humans. HIV Neurobehavioral Research Center Group (HNRC).

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Human immunodeficiency virus-1 RNA levels in cerebrospinal fluid exhibit a set point in clinically stable patients not receiving antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Intrathecal humoral immunologic response in neurologically symptomatic and asymptomatic patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

HIV-1 specificity of cerebrospinal fluid and serum IgG, IgM, and IgG1-G4 antibodies in relation to clinical disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Zidovudine reduces intrathecal immunoactivation in patients with early human immunodeficiency virus type 1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Upregulated expression of Fas and Fas ligand in brain through the spectrum of HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

GFAP and astrogliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid beta2-microglobulin, monocyte chemotactic protein-1, and soluble tumour necrosis factor alpha receptors before and after treatment with lamivudine plus zidovudine or stavudine

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Neuronal injury regulates fractalkine: relevance for HIV-1 associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Increased glutamate in CSF and plasma of patients with HIV dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Prevention of AIDS dementia by HAART does not depend on cerebrospinal fluid drug penetrance

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Increased glutamate in CSF and plasma of patients with HIV dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Immune activation and decreased tryptophan in patients with HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Increase of tryptophan in serum and in cerebrospinal fluid of patients with HIV infection during zidovudine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Significance of CSF total neopterin and biopterin in inflammatory neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Comparison of Immunologic Restoration and Virologic Response in Plasma, Tonsillar Tissue, and Cerebrospinal Fluid in HIV-1–Infected Patients Treated With Double Versus Triple Antiretroviral Therapy in Very Early Stages: The Spanish Earth-2 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Soluble urokinase receptor (uPAR, CD 87) is present in serum and cerebrospinal fluid in patients with neurologic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Caspase cascades in human immunodeficiency virus-associated neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Human immunodeficiency virus neurotropism: an analysis of viral replication and cytopathicity for divergent strains in monocytes and microglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Mononuclear phagocyte differentiation, activation, and viral infection regulate matrix metalloproteinase expression: implications for human immunodeficiency virus type 1-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Elevated cerebrospinal fluid and serum nitrate and nitrite levels in patients with central nervous system complications of HIV-1 infection: a correlation with blood-brain-barrier dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Tryptophan concentrations increase in cerebrospinal fluid and blood after zidovudine treatment in patients with HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Elevated cerebrospinal fluid sulfatide concentrations as a sign of increased metabolic turnover of myelin in HIV type I infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid viral load in HIV-1-infected patients without antiretroviral treatment: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid and plasma viral load in HIV-1-infected patients with various anti-retroviral treatment regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Clinical-neuropathologic correlation in HIV-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Microglia as mediators of inflammatory and degenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

The neuropathogenesis of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

The changing pattern of HIV neuropathology in the HAART era.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cytokines in the brain during viral infection: clues to HIV-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Oligoclonal IgG bands in cerebrospinal fluid and serum during asymptomatic human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Two phases of HIV RNA decay in CSF during initial days of multidrug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cytological and immunoglobulin findings in cerebrospinal fluid of symptomatic and asymptomatic human immunodeficiency virus (HIV) seropositive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid neopterin concentrations in central nervous system infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Intrathecal immune activation is associated with cerebrospinal fluid markers of neuronal destruction in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

World-wide variation in HIV-1 phenotypic susceptibility in untreated individuals: biologically relevant values for resistance testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Prevalence and predictive value of intermittent viremia with combination hiv therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Serum and cerebrospinal fluid levels of soluble intercellular adhesion molecule 1 (sICAM-1) in patients with HIV-1 associated neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

14-3-3 protein in CSF: an early predictor of SIV CNS disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Neurologic abnormalities and recovery of human immunodeficiency virus from cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

The reverse transcriptase sequence of human immunodeficiency virus type 1 is under positive evolutionary selection within the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Investigation of population diversity of human immunodeficiency virus type 1 in vivo by nucleotide sequencing and length polymorphism analysis of the V1/V2 hypervariable region of env.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Glial tau pathology in neurodegenerative diseases: their nature and comparison with neuronal tangles

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Human immunodeficiency virus type 1 gp120 induces apoptosis in human primary neurons through redox-regulated activation of neutral sphingomyelinase

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Platelet-activating factor production by human fetal microglia. Effect of lipopolysaccharides and tumor necrosis factor-alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Regulation of neural cell survival by HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Serum S-100beta as a possible marker of blood-brain barrier disruption

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Pathways to neuronal injury and apoptosis in HIV-associated dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

HIV-1 infection and AIDS: consequences for the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

V3 sequences of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Role of MIP-1beta and RANTES in HIV-1 infection of microglia: inhibition of infection and induction by IFNbeta

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Differences in human immunodeficiency virus type 1 V3 sequences from patients with and without AIDS dementia complex

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

HIV-1 replication in the plasma and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Chemokines and chemotaxis of leukocytes in infectious meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

The C-X-C chemokine IP-10 stimulates HIV-1 replication.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Indole amine deficiency in blood and cerebrospinal fluid from patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and noninflammatory diseases of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

The monocyte chemotactic protein-1 -2578G allele is associated with elevated MCP-1 concentrations in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Lamivudine in children with human immunodeficiency virus infection: a phase I/II study. The National Cancer Institute Pediatric Branch-Human Immunodeficiency Virus Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Molecular and cellular mechanisms of neuronal cell death in HIV dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Specific diagnostic methods for herpesvirus infections of the central nervous system: a consensus review by the European Union Concerted Action on Virus Meningitis and Encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Evidence for platelet-activating factor as a novel mediator in experimental stroke in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Chemokine expression and viral infection of the central nervous system: regulation of host defense and neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Immunoperoxidase staining of glial fibrillary acidic (GFA) protein polymerized in vitro: an ultramicroscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Extracellular matrix degradation by metalloproteinases and central nervous system diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Expression of gangliosides on glial and neuronal cells in normal and pathological adult human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Chemokine receptors in the brain: their role in HIV infection and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid markers in multiple sclerosis: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Tumour necrosis factor (TNF-alpha) and neurological disorders in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Fas antigen mRNA induction in postischemic murine brain

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

The soluble form of Fas molecule is elevated in parkinsonian brain tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

uPA and uPAR in fibrinolysis, immunity and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Increased CSF F2-isoprostane concentration in probable AD.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

High human immunodeficiency virus type 1 RNA load in the cerebrospinal fluid from patients with lymphocytic meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

1 reference

7 January 2021

The AIDS dementia complex: I. Clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

HIV-Producing T Cells in Cerebrospinal Fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

T-cell activation and memory phenotypes in cerebrospinal fluid during HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Enrichment of activated monocytes in cerebrospinal fluid during antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Recombinant plasma-type platelet-activating factor acetylhydrolase attenuates NMDA-induced hippocampal neuronal apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Comparison of human immunodeficiency virus biological phenotypes isolated from cerebrospinal fluid and peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid S-100beta and its relationship with AIDS dementia complex

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Enhanced expression of fractalkine in HIV-1 associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Interleukin-6 and granulocyte macrophage-csf in the cerebrospinal fluid from hiv infected subjects with involvement of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Microglial cell upregulation of HIV-1 expression in the chronically infected promonocytic cell line U1: the role of tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Neurolipidomics: an inflammatory perspective on fat in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

The two faces of HIV infection of cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid response to structured treatment interruption after virological failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Sequence analysis of the V3 loop in brain and spleen of patients with HIV encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Dynamics of brain-derived proteins in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Use of methodological standards in diagnostic test research. Getting better but still not good.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Chemokine induction by HIV-1: recruitment to the cause

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Early penetration of the blood-brain-barrier by HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Evaluation of an ultrasensitive p24 antigen assay as a potential alternative to human immunodeficiency virus type 1 RNA viral load assay in resource-limited settings

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

A potential role for interferon-alpha in the pathogenesis of HIV-associated dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: an indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Imbalance between IL-1 and IL-1 receptor antagonist in the cerebrospinal fluid of HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Highly active antiretroviral therapy improves neurocognitive functioning

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Glial fibrillary acidic protein in CSF of multiple sclerosis patients: relation to neurological deficit

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

S100B in brain damage and neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Elevated levels of soluble Fas and Fas ligand in cerebrospinal fluid of patients with AIDS dementia complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Novel markers of oxidative stress in actively progressive HIV dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Tumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Haptoglobin polymorphism, iron metabolism and mortality in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Relevance of protein nitration in brain injury: a key pathophysiological mechanism in neurodegenerative, autoimmune, or inflammatory CNS diseases and stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Elevated titers of cell-free interleukin-2 receptor in serum and cerebrospinal fluid specimens of patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Co-receptor antagonists as HIV-1 entry inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Increased neopterin levels in brains of patients with human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Undetectable tumor necrosis factor-alpha in spinal fluid from HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Amplification of HIV-1 provirus from cerebrospinal fluid and its correlation with neurologic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Amplification of human immunodeficiency virus provirus from cerebrospinal fluid: results of long-term clinical follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

A long-term latent reservoir for HIV-1: discovery and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid p24 antigen levels and intrathecal immunoglobulin G synthesis are associated with cognitive disease severity in HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Elevated neopterin and beta 2-microglobulin levels in blood and cerebrospinal fluid occur early in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Association between intrathecal anti-HIV-1 immunoglobulin G synthesis and occurrence of HIV-1 in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Detection of HIV-1 DNA and infectious virus in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Urokinase plasminogen activator receptor (uPAR; CD87) expression on monocytic cells and T cells is modulated by HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Increased levels of soluble Fas receptor and Fas ligand in the cerebrospinal fluid of HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Increased intrathecal release of soluble fractalkine in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Evaluation of CSF glial fibrillary acidic protein (GFAP) as a putative marker for HIV-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Evaluation of cerebrospinal fluid uPA, PAI-1, and soluble uPAR levels in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Distinct Populations of Human Immunodeficiency Virus Type 1 in Blood and Cerebrospinal Fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Induction of intercellular adhesion molecule-1 on human brain endothelial cells by HIV-1 gp120: role of CD4 and chemokine coreceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Tryptophan metabolites and brain disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Functional plasticity of microglia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Downregulation of Fas ligand by shedding

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Discordant Human Immunodeficiency Virus Type 1 drug resistance mutations, including K103N, observed in cerebrospinal fluid and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Biological markers in CSF and blood for axonal degeneration in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cerebrospinal fluid levels of IL-6 in patients with acute infections of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

CSF soluble Fas correlates with the severity of HIV-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Chemokine receptors on infiltrating leucocytes in inflammatory pathologies of the central nervous system (CNS).

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

High levels of anti-HIV-1 envelope antibodies in cerebrospinal fluid as compared to serum from patients with AIDS dementia complex

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Markers predicting progression of human immunodeficiency virus-related disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Cytokine expression in the brain during the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant?

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Intrathecal synthesis of anti-HIV IgG: correlation with increasing duration of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

HIV-1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting the uptake and stimulating the release of the amino acid

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Reactive oxygen species generated by glia are responsible for neuron death induced by human immunodeficiency virus-glycoprotein 120 in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Increased concentrations of 14-3-3 epsilon, gamma and zeta isoforms in cerebrospinal fluid of AIDS patients with neuronal destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

The effect of X4 and R5 HIV-1 on C, C-C, and C-X-C chemokines during the early stages of infection in human PBMCs

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

In vivo comparison of zidovudine resistance mutations in blood and CSF of HIV-1-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

In vitro evidence for a dual role of tumor necrosis factor-alpha in human immunodeficiency virus type 1 encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Role of the urokinase plasminogen activator system in patients with bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Neopterin in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Mitochondrial glutaminase enhances extracellular glutamate production in HIV-1-infected macrophages: linkage to HIV-1 associated dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Virological markers in the cerebrospinal fluid from HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Measuring HIV-1 RNA and interferon-alpha in the cerebrospinal fluid of AIDS patients: insights into the pathogenesis of AIDS Dementia Complex

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Monokine products as predictors of AIDS dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Comparison of human immunodeficiency virus type 1 RNA sequence heterogeneity in cerebrospinal fluid and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

Relationship of cerebrospinal fluid immune activation associated factors to HIV encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0072-9752%2807%2985017-2

7 January 2021

10.1016/S0072-9752(07)85017-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808988%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference